FOXM1-Cx31 Axis Drives Pancreatic Cancer Stem Cell-Like Properties and Chemoresistance

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Pancreatic cancer is a deadly disease with limited treatment options.
• The role of Connexin 31 (Cx31) in pancreatic cancer development and progression is not well understood.

Purpose of the Study:

• To investigate the expression and function of Cx31 in pancreatic cancer.
• To explore the correlation between Cx31 expression and patient outcomes.
• To elucidate the molecular mechanisms underlying Cx31's role in pancreatic cancer.

Main Methods:

• Analysis of Cx31 expression in public databases and experimental models.
• Evaluation of Cx31's impact on cancer cell proliferation, stemness, migration, and chemoresistance.
• Transcriptome analysis and bioinformatics to identify associated pathways and regulatory factors.

Main Results:

• Cx31 is upregulated in pancreatic cancer tissues and linked to poorer survival.
• Cx31 promotes key cancer hallmarks including ADM, stemness, proliferation, migration, metastasis, and chemoresistance.
• Cx31 expression is regulated by FOXM1 and influences Wnt and Notch signaling pathways.

Conclusions:

• Cx31 plays a significant role in pancreatic cancer initiation, progression, and treatment resistance.
• Cx31 is a potential therapeutic target for pancreatic cancer.
• The FOXM1-Cx31 axis represents a promising target for overcoming therapeutic resistance.